1. BMG. Jahresstatistik meldepflichtiger Infektionskrankheiten ab 2000. Bundesministerium für Gesundheit. 2011. http://bmg.gv.at/home/Schwerpunkte/Krankheiten/Uebertragbare_Krankheiten/Statistiken/Jahresstatistik_meldepflichtiger_Infektionskrankheiten_ab_2000 . Accessed 14 Jan 2012.
2. WHO. Guidelines for the treatment of malaria, second edition. World Health Organization. 2010. http://whqlibdoc.who.int/publications/2010/9789241547925_eng.pdf . Accessed 14 Jan 2012.
3. Robak O, Bojic A, Locker GJ, Laczika K, Ramharter M, Staudinger T. The use of drotrecogin alfa in severe falciparum malaria. Anaesth Intensive Care. 2010;38(4):751–4.
4. WHO. Severe falciparum malaria. World Health Organization, communicable diseases cluster. Trans R Soc Trop Med Hyg. 2000;94(Suppl 1):S1–90.
5. Miller KD, Greenberg AE, Campbell CC. Treatment of severe malaria in the United States with a continuous infusion of quinidine gluconate and exchange transfusion. N Engl J Med. 1989;321(2):65–70.